Table 5.

Clinical Characteristics of Survivors vs Non-Survivors.

	Survivors to 28-Days (n = 379)	Non-Survivors to 28-Days (n = 21)	p-value
Age (years), median (IQR)	7.9 (3.5–13.8)	5.4 (1.6–13.0)	0.21
Female, %	46%	43%	0.96
Bone Marrow Transplant or Oncologic Diagnosis, %	72%	71%	0.87
Solid Organ Transplant, %	27%	19%	0.98
Non-ICU Location, %	88%	33%	<0.001
Platelet Count (K/mcL), median (IQR)	81 (33–190)	57 (46–151)	0.82
Bacterially Infected, %	36%	57%	0.08
PERSEVERE Mortality Risk, median (IQR)	0.01 (0.01–0.01)	0 (0.01–0.01)	0.005
PERSEVERE-II Mortality Risk, median (IQR)	0.007 (0.007–0.17)	0.19 (0.007–0.33)	0.005
Clinical Deterioration, %	13%	57%	<0.001